US Tariffs Indian Market is entering a “deep-freeze” phase in mid-January 2026 as the expected US-India trade breakthrough has stalled and high tariffs remain in force. With Washington signalling that India is now “back of the line,” markets are shifting from “deal hope” to “risk management”—watching two big triggers: the US Congress debate on a Russia sanctions bill carrying a 500% tariff threat, and India’s own domestic growth-and-Budget narrative that could cushion the impact on export-heavy sectors.
A missed call heard round the world
Darned 14.01.2026 : The “Grand Bargain” that investors were betting on for early 2026 has officially hit a wall. As of mid-January, US-India trade talks have entered a state of “deadlock,” and the “Reciprocal Deal” we once hoped for has been replaced by a period of strategic friction and punitive tariffs.
1. The “Missed Call” Heard ‘Round the World
In a surprising public display of frustration, US Commerce Secretary Howard Lutnick recently revealed that the long-awaited trade pact faltered at the finish line. According to Lutnick, the deal was ready, but a final leader-to-leader call between PM Modi and President Trump—intended to seal the deal—never happened.
The Back of the Line: While India waited, the US finalized trade deals with Vietnam and the Philippines. Washington’s message is clear: India has been pushed to the “back of the line.”
The “Partnership” Gap: Despite a high-level call yesterday (Jan 13) between External Affairs Minister S. Jaishankar and US Secretary of State Marco Rubio, the focus has shifted from a trade deal to “managing differences” over defense and critical minerals.
2. The 500% Shadow: The Russia Sanctions Bill
The biggest risk to the Indian stock market right now isn’t the current tariffs, but the Russia Sanctions Bill (The “Sanctioning Russia Act of 2025”), which President Trump has officially “green-lit.”
- The Trigger: This bill proposes automatic tariffs of at least 500% on goods from any country that continues to buy Russian oil or uranium.
- The Impact: If passed by Congress next week, it could effectively shut down India’s $85 billion annual export engine to the US. This is no longer about a 2% tax; it’s about a total trade blockade.
3. Sector Watch: Winners, Losers, and the “Crisis Zone”
The Nifty 50 has seen its worst start to a year in a decade, and the sector outlook has turned sharply defensive:
- The Crisis Zone (Textiles, Gems, & Jewelry): These labor-intensive sectors are the hardest hit. With 50% tariffs now firmly in place and no relief in sight, companies like Gokaldas Exports and Rajesh Exports are facing significant order cancellations as US buyers pivot to “Tariff-Free” Vietnam.
+1 - The New Casualty (Energy & PSUs): Oil and gas giants like ONGC and BPCL are under pressure as the US demands a “full stop” to Russian oil imports. Reliance Industries has already reportedly halted Russian crude imports for January to avoid the 500% tariff threat.
- The Resilient (Pharma & IT): Nifty Pharma remains the only true shelter. Generic drugs are still exempted because the US healthcare system cannot survive without them. Similarly, IT Services (TCS, HCLTech) remain insulated from goods-based tariffs.
4. The “Dragon-Elephant” Pivot: A Tactical Thaw?
The most unexpected development of 2026 is India’s tactical shift toward China. Faced with US trade aggression, New Delhi is reportedly considering easing 5-year-old curbs on Chinese firms and government contracts.
By reopening doors to Chinese technicians and supply chains, India is attempting a “Strategic Autonomy” play—diversifying away from a volatile US trade relationship.
Investor Conclusion: Preparing for Volatility
The “Trade Deal” rally is dead. For the rest of early 2026, the Indian market will be driven by two things: Domestic Budget 2026 expectations and the US Congressional vote on the 500% tariff bill.
The Strategy: Avoid export-heavy sectors that lack a “moat.” Focus on domestic-facing financials and defensive Pharma. The “Trade Winds” are blowing cold, and for now, survival is the name of the game.
Read our article : The Trump Tariffs & India’s Market
This article is for informational purposes only.Content for this article was developed with the assistance of Gemini, a large language model from Google
Disclaimer: This article provides general information based on current industry and political / trade trends as of early 2026 and it’s not a financial advice. We are not SEBI-registered investment advisors, and this content does not constitute investment advice. Consult your financial advisor before making any investment decision.
For more information Contact us